Advertisement
UK markets close in 8 hours 16 minutes

  • FTSE 100

    8,213.49
    0.00 (0.00%)
     

  • FTSE 250

    20,164.54
    0.00 (0.00%)
     

  • AIM

    771.53
    0.00 (0.00%)
     

  • GBP/EUR

    1.1647
    -0.0012 (-0.11%)
     

  • GBP/USD

    1.2537
    -0.0027 (-0.21%)
     

  • Bitcoin GBP

    50,757.12
    -483.73 (-0.94%)
     

  • CMC Crypto 200

    1,367.60
    +2.47 (+0.18%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • DOW

    38,852.27
    +176.59 (+0.46%)
     

  • CRUDE OIL

    78.46
    -0.02 (-0.03%)
     

  • GOLD FUTURES

    2,328.90
    -2.30 (-0.10%)
     

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,486.82
    -91.48 (-0.49%)
     

  • DAX

    18,175.21
    +173.61 (+0.96%)
     

  • CAC 40

    7,996.64
    0.00 (0.00%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Shire to roadshow benchmark US dollar bond Sept 12-15: Source

Reuters - UK Focus

(Adds loan details)

By Hillary Flynn

NEW YORK, Sept 7 (IFR) - Drugmaker Shire Plc will start marketing a benchmark US dollar bond early next week, according to a note sent to investors seen by IFR.

Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) and Morgan Stanley (Xetra: 885836 - news) are arranging the fixed-income investor meetings, which will be held in the US and London between September 12-15, according to the note.

Bank of America (Swiss: BAC-USD.SW - news) is acting as logistics coordinator on the roadshow.

Shire (Xetra: S7E.DE - news) announced earlier this year that it had agreed to buy Baxalta International Inc in a US$32bn cash and stock offer.

In January, the company signed an US$18bn fully underwritten bank facility to finance the acquisition. (Reporting by Hillary Flynn; Editing by Paul Kilby and Shankar Ramakrishnan)